Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
New data clarifies the role of heart pumps in shock
This narrative review examines the use of VA-ECMO and microaxial-pump strategies in patients with cardiogenic shock and ST-elevation myocard…
New research looks at how heart pumps and bypass machines help patients with severe heart damage after a heart attack.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
An RV-first framework addresses controversies in tricuspid intervention and right ventricular support for cardiogenic shock
New framework aims to improve care for heart failure patients
This narrative review explores the role of transcatheter tricuspid interventions and mechanical circulatory support for patients with advanc…
Doctors are looking for better ways to treat heart failure and cardiogenic shock using a new approach to manage the right side of the heart.
mAFP support associated with lower odds of mortality in isolated LM culprit lesion
Heart surgery complexity predicts survival for patients in cardiogenic shock
This RCT substudy of 355 patients with infarct-related cardiogenic shock and multivessel disease found that mAFP support was associated with…
A new analysis shows that the complexity of a patient's heart disease significantly impacts their survival after a heart attack.
Mechanical circulatory support devices improve hemodynamics and survival in selected heart failure and cardiogenic shock populations
Mechanical heart devices can improve survival for heart failure patients
This narrative review examines the role of mechanical circulatory support devices (MCSDs) in patients with heart failure and cardiogenic sho…
Mechanical circulatory support devices can improve survival and quality of life for specific patients facing heart failure and cardiogenic s…
Pembrolizumab-induced myositis and cardiogenic shock may be reversible with early immunosuppression and circulatory support
Immune therapy for thymoma can cause severe heart and muscle damage
This case report and literature review describes a patient with stage IV thymoma who developed severe myositis and cardiogenic shock followi…
A new case report reveals how a specific cancer treatment can cause severe heart and muscle issues, requiring intensive life support.
Geographic and socioeconomic disparities limit access to mechanical circulatory support and heart transplantation
Heart Devices and Transplants Are Out of Reach for Many
This narrative review with scoping methods examines the global landscape of mechanical circulatory support (MCS) and heart transplantation f…
A new review finds heart transplants and mechanical support are concentrated in wealthy regions, leaving many patients without access.
Microaxial flow pump mortality benefit associated with early CICU discharge in STEMI-CS patients
Trial Shows Microaxial Flow Pump Benefits for Heart Failure Patients
This post hoc exploratory analysis of a randomized trial involving 355 patients with STEMI-CS found that early CICU discharge was associated…
A trial of 355 patients with heart complications suggests that identifying those who recover quickly may help manage risks from device thera…
Impella CP Reduces Escalation Need in STEMI Cardiogenic Shock
Trial shows micro-axial flow pump reduces escalation rates
In non-comatose STEMI cardiogenic shock patients, Impella CP reduced escalation to higher tMCS vs standard care, but escalated patients had …
A new analysis shows that using a specific heart pump can delay the need for more invasive treatments in patients with severe heart failure.
Aortic valve opening status best predicts VA-ECMO weaning success in cardiogenic shock
Heart ultrasound helps predict success for patients on heart machines
A meta-analysis of 37 studies (3,458 patients) found that aortic valve opening status (AUC 0.88) and LVOT-VTI (AUC 0.85) have the highest di…
New data shows specific heart ultrasound measurements can help doctors predict if patients can safely come off life-saving heart support.
Palliative care consultation increases do-not-resuscitate orders and decreases healthcare utilization in cardiac arrest and cardiogenic shock patients
Palliative care linked to better choices for cardiac arrest patients
This narrative review examines palliative care for patients with cardiac arrest and cardiogenic shock and their caregivers. The authors repo…
A review suggests palliative care helps patients with cardiac arrest make decisions about life-sustaining treatments and lowers healthcare c…
AI applications in acute care showed potential but face significant implementation challenges
AI Is Quietly Changing How ERs Save Lives. Here’s How
This narrative review examined artificial intelligence (AI) applications in patients within emergency departments and intensive care units.
Artificial intelligence is moving into emergency rooms to help doctors spot life-threatening problems faster, but it’s not ready to run the …
Questions about Cardiogenic Shock
Does using a pulmonary artery catheter lower the risk of dying from cardiogenic shock?
Yes, observational studies suggest pulmonary artery catheter use is linked to lower in-hospital mortality in cardiogenic shock, but randomized trials are lacking.
Full answer →Will an IABP device improve my chances of survival from cardiogenic shock?
An IABP may improve survival chances in advanced cardiogenic shock, but results are mixed and depend on the patient's specific condition.
Full answer →Does going to a hospital with higher cardiac capability help cardiogenic shock patients?
Going to a hospital with higher cardiac capability significantly lowers the risk of death for patients with cardiogenic shock compared to lower-tier facilities.
Full answer →Can artificial intelligence help treat cardiogenic shock in the emergency room?
AI shows potential for risk stratification and treatment support in cardiogenic shock, but real-world use in the ER remains limited by data quality and implementation challenges.
Full answer →All Cardiogenic Shock Articles
- Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
- Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
- An RV-first framework addresses controversies in tricuspid intervention and right ventricular support for cardiogenic shock
- mAFP support associated with lower odds of mortality in isolated LM culprit lesion
- Mechanical circulatory support devices improve hemodynamics and survival in selected heart failure and cardiogenic shock populations
- Pembrolizumab-induced myositis and cardiogenic shock may be reversible with early immunosuppression and circulatory support
- Geographic and socioeconomic disparities limit access to mechanical circulatory support and heart transplantation
- Microaxial flow pump mortality benefit associated with early CICU discharge in STEMI-CS patients
- Impella CP Reduces Escalation Need in STEMI Cardiogenic Shock
- Aortic valve opening status best predicts VA-ECMO weaning success in cardiogenic shock
- Palliative care consultation increases do-not-resuscitate orders and decreases healthcare utilization in cardiac arrest and cardiogenic shock patients
- AI applications in acute care showed potential but face significant implementation challenges
- Higher hospital cardiac capability tiers associated with lower mortality in cardiogenic shock hospitalizations
- Meta-analysis finds IABP may improve 60-day outcomes in advanced heart failure-related cardiogenic shock
- PAC use in cardiogenic shock associated with lower mortality but higher sepsis risk in meta-analysis